Related Experiment Videos
Coagulation and atherothrombotic disease.
1Academic Unit of Molecular Vascular Medicine, Leeds Institute of Genetics Health and Therapeutics, Faculty of Medicine and Health, The LIGHT Laboratories, Clarendon Way, University of Leeds, Leeds LS2 9JT, UK. r.ajjan@leeds.ac.uk
Atherosclerosis
|December 14, 2005
Summary
Atherothrombotic disease results from gene-environment interactions affecting blood clot formation. Understanding these factors aids in developing treatments and early prevention strategies for at-risk individuals.
Area of Science:
- Cardiovascular Science
- Genetics
- Biochemistry
Background:
- Atherothrombotic disease involves complex gene-environment interactions.
- Early stages are silent, progressing to occlusive thrombus formation and clinical symptoms.
- Genetic variations and environmental factors impact clotting cascade elements, altering clot structure and lysis resistance.
Purpose of the Study:
- To elucidate the intricate gene-environment interactions in thrombus formation.
- To enhance understanding of atherothrombotic disease pathogenesis.
- To inform the development of targeted treatments and preventative measures.
Main Methods:
- Analysis of gene-environment interactions in clotting cascade.
- Investigation of genetic variations influencing protein structure and function.
- Assessment of environmental factors affecting thrombosis risk.
Main Results:
- Identified key gene-environment interactions influencing thrombus formation.
- Demonstrated how genetic and environmental factors modify clot properties.
- Established a link between altered protein characteristics and clot lysis resistance.
Conclusions:
- Detailed understanding of gene-environment interactions is crucial for elucidating disease pathogenesis.
- This knowledge facilitates the development of more effective therapeutic strategies.
- Early identification of at-risk individuals through understanding these interactions enables preventative measures.